Lipid disorders

Drug update

2018; 19(6): 57-59

An update on lipid therapy with PCSK9 inhibitors

LEON A. SIMONS

2017; 18(1): 22-27

Managing lipid abnormalities in type 2 diabetes

Richard O'Brien

Drug update

2016; 17(10): 51-53

Alirocumab and evolocumab: a new era in cholesterol control

Leon A Simons

2015; 16(8): 20-26

Familial hypercholesterolaemia: challenges in primary care

Tom Brett, Gerald Watts, Jacquie Garton-Smith, Damon Bell, Alistair W Vickery, Jing Pang, Diane Arnold-Reed

2012; 13(1): 33-42

Update on lipid management: commonly asked questions

Ian Hamilton-Craig

2011; 12(12): 29-34

The practical value of the metabolic syndrome

Namson S Lau, Nicholas R Fuller, Ian D Caterson

Dermatology clinic

2010; 11(7): 69-71

A case of xanthelasma palpebrarum

Bruce Tate

2008; 9(11): 48-54

Lipid management – what’s hot and what’s not?

Leon A Simons

2008; 9(1): 39-46

Familial hypercholesterolaemia: walking time bombs and digging for gold

Ian Hamilton-Craig

2007; 8(12): 25-33

Treatment resistant dyslipidaemia: managing patients who respond poorly to lipid monotherapy

David Sullivan

Clinical case review

2007; 8(6): 61

A 65-year-old on statins with muscle pain and weakness

Leon A Simons

2007; 8(5): 57-60

Eating well to improve your blood fats

Connie Stanton, Melissa Carapetis, Pat Phillips

2007; 8(1): 21-29

Lipid therapy: a 2007 update

Leon A Simons

Case studies in diabetes care

2006; 7(12): 65-70

ABCss: C is for cholesterol

Pat Phillips

2006; 7(1): 20-26

Lipid therapy: an update on the evidence

Leon A Simons

Dermatology clinic

2005; 6(8): 73-74

Eruptive xanthomas

Bruce Tate

Drug update

2005; 6(1): 48-50

Cardiovascular disease, cholesterol and statin drugs

Leon A Simons

2004; 5(12): 34-40

Familial hypercholesterolaemia – Part 2: Treatment options and screening approaches

John R Burnett, Gerald Watts

2004; 5(11): 40-47

Familial hypercholesterolaemia – Part 1: An unmet need in the management of a lipid disorder

John R Burnett, Gerald Watts

2004; 5(3): 36-42

Intermittent claudication: an opportunity for secondary prevention

John Fletcher

Clinical investigations from the RACP

2004; 5(1): 48-51

Investigation and management of xanthoma

Leon A Simons

2003; 4(10): 44-53

The ABC of HDL: a paradigm shift in managing lipid disorders

Gerald Watts, John R Burnett

2001; 2(11): 33-39

Lipid disorders: the challenge of patient management

Leon A Simons

Clinical case review

2001; 2(4): 114-115

An elderly patient on a statin drug

Leon A Simons